Profile
Innogest is a venture capital firm based in Turin, Italy, founded in 2005. The firm is led by a team of experienced investors and entrepreneurs, with a focus on fostering innovation in the technology and healthcare sectors. Innogest distinguishes itself by working closely with its portfolio companies, leveraging its market expertise to drive growth and innovation.
The firm primarily invests in early-stage ventures, focusing on Series A and Series B rounds. Innogest typically invests between $1-5 million per deal and has a global investment reach, with a primary focus on Europe. The firm manages several funds, although specific assets under management are not publicly disclosed.
Notable companies in Innogest's portfolio include Newronika - therapeutic devices, BetaGlue Therapeutics - drug discovery, GreenBone - therapeutic devices, Everli - internet retail, and Soul-K - other commercial products. These investments highlight Innogest's commitment to supporting businesses at the forefront of technological and healthcare advancements.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.